This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Dermatologic Disorders  • Pain  • Dermatologic Disorders, Other  • Genetics  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Screening for SCN9A Mutations: Exclusion of a Causal Role of SCN10A and SCN11A

Joost P. H. Drenth, MD, PhD; Rene H. M. te Morsche, MS; Sahar Mansour, BMBS, FRCP; Peter S. Mortimer, MD, FRCP

Arch Dermatol. 2008;144(3):320-324.

Objectives  To elucidate the rate of missense mutations in the SCN9A gene (which encodes sodium channel Na_v1.7) (OMIM 603415) among patients with primary erythermalgia and to examine the possibility that other sodium channels can cause the disease.

Design  Case series.

Setting  Department of Medicine, Radboud University Nijmegen, the Netherlands.

Participants  Six patients with sporadic and 9 with unique familial primary erythermalgia.

Interventions  Questionnaire to determine clinical profile and sequencing of all coding exons from SCN9A and those of SCN10A (OMIM 604427) and SCN11A (OMIM 604385) in 2 selected cases with a clear family history of the disease.

Main Outcome Measures  Detection of SCN9A mutation.

Results  We identified 1 patient with an SCN9A mutation. This mutation (I848T) has been associated with primary erythermalgia. Sequencing of 2 other candidate genes did not show mutations in 2 patients with familial primary erythermalgia.

Conclusions  The Na_v1.7 voltage-gated sodium channels are related to syndromes of altered nociception. We detected a low SCN9A mutation rate in patients with primary erythermalgia, suggesting that pain syndromes in the skin may have a polygenic basis.

Author Affiliations: Division of Gastroenterology and Hepatology, Department of Medicine, University Medical Center St Radboud, Nijmegen, the Netherlands (Dr Drenth and Mr te Morsche); and South West Thames Regional Genetics Service (Dr Mansour), and Cardiac and Vascular Sciences, St George's Hospital Medical School (Dr Mortimer), London, England.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

Dermatology in the Postgenomic Era: Harnessing Human Variation for Personalized Medicine
Anthony E. Oro
Arch Dermatol. 2008;144(3):389-391.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dermatology in the Postgenomic Era: Harnessing Human Variation for Personalized Medicine
Oro
Arch Dermatol 2008;144:389-391.
FULL TEXT